Donepezil Hydrochloride Patent Expiration

Donepezil Hydrochloride was first introduced by Eisai Inc in its drug Aricept on Nov 25, 1996. Other drugs containing Donepezil Hydrochloride are Adlarity, Aricept Odt. 41 different companies have introduced drugs containing Donepezil Hydrochloride.


Donepezil Hydrochloride Patents

Given below is the list of patents protecting Donepezil Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Adlarity US10966936 Systems comprising a composite backing and methods for long term transdermal administration Aug 11, 2038 Corium
Adlarity US10835499 Systems and methods for long term transdermal administration May 20, 2038 Corium
Adlarity US11648214 Systems and methods for long term transdermal administration Sep 23, 2037 Corium
Adlarity US10016372 Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery Jul 26, 2037 Corium
Adlarity US10300025 Donepezil transdermal delivery system Jul 26, 2037 Corium
Adlarity US10307379 Donepezil transdermal delivery system Jul 26, 2037 Corium
Adlarity US11103463 Methods for treating alzheimer's disease with donepezil transdermal system Jul 26, 2037 Corium
Adlarity US9993466 Donepezil transdermal delivery system Jul 26, 2037 Corium
Adlarity US11679086 Systems comprising a composite backing and methods for long term transdermal administration May 26, 2037 Corium
Adlarity US12161767 Systems and methods for long term transdermal administration Dec 30, 2036 Corium
Adlarity US12168075 Systems comprising a composite backing and methods for long term transdermal administration Dec 30, 2036 Corium
Aricept US8481565 Method for stabilizing anti-dementia drug Oct 04, 2026 Eisai Inc
Aricept Odt US7727548 Rapidly disintegrable tablet containing polyvinyl alcohol Jun 23, 2022

(Expired)

Eisai Inc
Aricept US6245911 Donepezil polycrystals and process for producing the same Dec 01, 2018

(Expired)

Eisai Inc
Aricept Odt US7727552 Oral pharmaceutical preparations decreased in bitterness by masking Mar 26, 2018

(Expired)

Eisai Inc
Aricept US5985864 Polymorphs of donepezil hydrochloride and process for production Dec 30, 2016

(Expired)

Eisai Inc
Aricept US6140321 Polymorphs of donepezil hydrochloride and process for production Dec 30, 2016

(Expired)

Eisai Inc



Donepezil Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Donepezil Hydrochloride Generic API Manufacturers

Several generic applications have been filed for Donepezil Hydrochloride. The first generic version for Donepezil Hydrochloride was by Sun Pharmaceutical Industries Inc and was approved on Dec 11, 2009. And the latest generic version is by Hisun Pharmaceutical Hangzhou Co Ltd and was approved on Jul 27, 2018.

Given below is the list of companies who have filed for Donepezil Hydrochloride generic, along with the locations of their manufacturing plants worldwide.